Acute care hospitals in Canada (n = 419) and participant enrolment in a CIHR-funded clinical study on COVID-19 (randomized controlled trials or cohort studies)*
Characteristic | Hospitals in Canada that enrolled at least 1 participant n = 97 | Hospitals in Canada that enrolled no participants n = 322 | ||
---|---|---|---|---|
No. of hospitals | ||||
University | 25 | 10 | ||
University-affiliated | 39 | 26 | ||
Community | 33 | 258 | ||
NA | 0 | 28 | ||
No. of beds | ||||
Median (IQR) | 422 (280–521) | 76 (35–166) | ||
NA | 1 | 75 | ||
Total | 40 975 | 28 012 | ||
Research staff participating in CIHR-funded studies on COVID-19 (FTE) | ||||
Median (IQR) | 1.25 (0.0–5.5) | 0 (0–0) | ||
NA | 27 | 182 | ||
Research team available outside working hours | Yes = 33, No = 34, NA = 30 | Yes = 22, No = 122, NA = 178 | ||
Local experience with deferred consent | Yes = 53, No = 15, NA = 29 | Yes = 29, No = 117, NA = 176 | ||
Local experience with co-enrolment | Yes = 56, No = 12, NA = 29 | Yes = 30, No = 114, NA = 178 | ||
Research pharmacy | Yes = 65, No = 3, NA = 29 | Yes = 32, No = 114, NA = 176 | ||
Province | Enrolled at least 1 participant n = 97 | Enrolled no participants n = 322 | Percentage of hospitals participating in studies at the provincial level | Provincial distribution of hospitals participating in studies n = 97 |
Alberta | 13 | 17 | 43.3 | 13.4 |
British Columbia | 13 | 31 | 29.5 | 13.4 |
Manitoba | 3 | 11 | 2.1 | 3.1 |
New Brunswick | 2 | 20 | 9.1 | 2.1 |
Newfoundland and Labrador | 2 | 18 | 10 | 2.1 |
Nova Scotia | 1 | 19 | 5 | 1 |
Ontario | 43 | 75 | 36.4 | 44.3 |
Quebec | 18 | 109 | 14.2 | 18.5 |
Saskatchewan | 2 | 14 | 12.5 | 2.1 |
Note: CIHR = Canadian Institutes of Health Research, FTE = full-time equivalent, IQR = interquartile range, NA = not available.
↵* The full list of hospitals is available in Appendix 1, Table S3 (available at www.cmaj.ca/lookup/doi/10.1503/cmaj.230760/tab-related-content).